{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:32:58Z","timestamp":1793161978523,"version":"4.5.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Previous studies have shown the metabolic and regulatory significance of CYP46A1 in the adult retina; however, its role in the developing retina is unknown. Here, we evaluate CYP46A1 expression and the impact of its activation in the developing mouse retina under normal and pathological conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seven-day-old (P7) C57BL\/6\u202fJ mice maintained in room air (controls) or subjected to oxygen-induced retinopathy (OIR) were treated with\/without 20\u202fmg\/kg efavirenz (EFV), a CYP46A1 activator administered intraperitoneally from P7 to P17.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Retinal cross sections and flat mounts were prepared to study retinal vasculature morphology, M\u00fcller and microglia activation, and ganglion cell viability. EFV treatment significantly reduced pathological neovascularization and the size of avascular and hypoxic areas in OIR mice retinas. EFV treatment additionally limited reactive gliosis and microglia activation and improved retinal ganglion cell survival in OIR mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The current study demonstrates the developmental regulation of CYP46A1 and the dysregulated expression and levels of the downstream metabolite 24-Hydroxycholesterol (24HC) in OIR mice. The study further suggests that EFV treatment (in part via CYP46A1 activation) may improve key pathological features associated with pathological neovascularization in OIR mice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1745351","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:27:54Z","timestamp":1771824474000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Efavirenz treatment improves retinal vaso-obliteration and pathological neovascularization in a mouse model of retinopathy of prematurity"],"prefix":"10.3389","volume":"13","author":[{"given":"Briah","family":"Bailey","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, School of Graduate Studies, Meharry Medical College","place":["Nashville, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Rudd Zhong Manis","sequence":"additional","affiliation":[{"name":"Department of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University","place":["Augusta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri","family":"Seth","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Graduate Studies, Meharry Medical College","place":["Nashville, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhra","family":"Rajpurohit","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical College of Georgia at Augusta University","place":["Augusta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allston","family":"Oxenrider","sequence":"additional","affiliation":[{"name":"Department of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University","place":["Augusta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela M.","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Graduate Studies, Meharry Medical College","place":["Nashville, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravirajsinh N.","family":"Jadeja","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Graduate Studies, Meharry Medical College","place":["Nashville, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menaka C.","family":"Thounaojam","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Graduate Studies, Meharry Medical College","place":["Nashville, TN, United States"]},{"name":"Department of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University","place":["Augusta, GA, United States"]},{"name":"Department of Ophthalmology, Medical College of Georgia at Augusta University","place":["Augusta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00431-011-1610-7","article-title":"Educational paper: retinopathy of prematurity","volume":"171","author":"Casteels","year":"2012","journal-title":"Eur J Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/aos.12049","article-title":"The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge","volume":"92","author":"Cavallaro","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5409\/wjcp.v5.i1.35","article-title":"Retinopathy of prematurity: past, present and future","volume":"5","author":"Shah","year":"2016","journal-title":"World J Clin Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye (Lond)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3980\/j.issn.2222-3959.2013.02.23","article-title":"Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options","volume":"6","author":"Mutlu","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF02044227","article-title":"Glaucoma as a cause of poor vision in severe retinopathy of prematurity","volume":"231","author":"Hartnett","year":"1993","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/bjo.84.2.138","article-title":"Long term refractive outcome in eyes of preterm infants with and without retinopathy of prematurity: comparison of keratometric value, axial length, anterior chamber depth, and lens thickness","volume":"84","author":"Choi","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/bjo.80.4.343","article-title":"Advanced cicatricial retinopathy of prematurity--outcome and complications","volume":"80","author":"Knight-Nanan","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/s0161-6420(01)00660-1","article-title":"Adult retinopathy of prematurity: outcomes of rhegmatogenous retinal detachments and retinal tears","volume":"108","author":"Kaiser","year":"2001","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3390\/jcm9061921","article-title":"Ursodeoxycholic acid halts pathological neovascularization in a mouse model of oxygen-induced retinopathy","volume":"9","author":"Thounaojam","year":"2020","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3390\/biom11050626","article-title":"Glycine-conjugated bile acids protect RPE tight junctions against oxidative stress and inhibit choroidal endothelial cell angiogenesis in vitro","volume":"11","author":"Warden","year":"2021","journal-title":"Biomolecules"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/biom11020292","article-title":"Pharmacological and metabolic significance of bile acids in retinal diseases","volume":"11","author":"Win","year":"2021","journal-title":"Biomolecules"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1161\/ATVBAHA.116.307558","article-title":"Cytochrome P450 oxidase 2C inhibition adds to omega-3 long-chain polyunsaturated fatty acids protection against retinal and choroidal neovascularization","volume":"36","author":"Gong","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ebiom.2016.09.025","article-title":"Fenofibrate inhibits cytochrome P450 Epoxygenase 2C activity to suppress pathological ocular angiogenesis","volume":"13","author":"Gong","year":"2016","journal-title":"EBioMedicine"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1021\/pr1008898","article-title":"Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain","volume":"10","author":"Liao","year":"2011","journal-title":"J Proteome Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1172\/JCI63816","article-title":"Abnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis","volume":"122","author":"Omarova","year":"2012","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e37926","DOI":"10.1371\/journal.pone.0037926","article-title":"Spatial distribution of the pathways of cholesterol homeostasis in human retina","volume":"7","author":"Zheng","year":"2012","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.ajpath.2014.05.024","article-title":"Retinal and nonocular abnormalities in Cyp27a1(\u2212\/\u2212)Cyp46a1(\u2212\/\u2212) mice with dysfunctional metabolism of cholesterol","volume":"184","author":"Saadane","year":"2014","journal-title":"Am J Pathol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1167\/iovs.10-6021","article-title":"Cholestenoic acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain","volume":"52","author":"Mast","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","article-title":"An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha","volume":"383","author":"Janowski","year":"1996","journal-title":"Nature"},{"key":"ref22","first-page":"3029","article-title":"Differential bile acids biosynthetic pathways in the developing retina and in the oxygen-induced model of retinopathy of prematurity","volume":"62","author":"Thounaojam","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"103568","DOI":"10.18632\/oncotarget.21592","article-title":"STAT3-mediated activation of miR-21 is involved in down-regulation of TIMP3 and neovascularization in the ischemic retina","volume":"8","author":"Gutsaeva","year":"2017","journal-title":"Oncotarget"},{"key":"ref24","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.preteyeres.2014.03.002","article-title":"Cholesterol in the retina: the best is yet to come","volume":"41","author":"Pikuleva","year":"2014","journal-title":"Prog Retin Eye Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1194\/jlr.R010538","article-title":"The ins and outs of cholesterol in the vertebrate retina","volume":"51","author":"Fliesler","year":"2010","journal-title":"J Lipid Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ajpath.2018.10.013","article-title":"Retinal vascular abnormalities and microglia activation in mice with deficiency in cytochrome P450 46A1-mediated cholesterol removal","volume":"189","author":"Saadane","year":"2019","journal-title":"Am J Pathol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s13311-019-00737-0","article-title":"CYP46A1 activation by Efavirenz leads to behavioral improvement without significant changes in amyloid plaque load in the brain of 5XFAD mice","volume":"16","author":"Petrov","year":"2019","journal-title":"Neurotherapeutics"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"11876","DOI":"10.1074\/jbc.M116.723577","article-title":"Mapping of the allosteric site in cholesterol hydroxylase CYP46A1 for Efavirenz, a drug that stimulates enzyme activity","volume":"291","author":"Anderson","year":"2016","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neuropharm.2017.04.038","article-title":"The dual modulatory effects of efavirenz on GABA(a) receptors are mediated via two distinct sites","volume":"121","author":"Huang","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/hep.23647","article-title":"Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells","volume":"52","author":"Blas-Garcia","year":"2010","journal-title":"Hepatology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"12837","DOI":"10.1038\/s41598-018-29978-3","article-title":"Efavirenz exposure, alone and in combination with known drugs of abuse, engenders addictive-like bio-behavioural changes in rats","volume":"8","author":"Moller","year":"2018","journal-title":"Sci Rep"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00109-022-02195-2","article-title":"Neurovascular abnormalities in retinopathy of prematurity and emerging therapies","volume":"100","author":"Dai","year":"2022","journal-title":"J Mol Med (Berl)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"9172","DOI":"10.3390\/ijms24119172","article-title":"Characterization of macroglia response during tissue repair in a laser-induced model of retinal degeneration","volume":"24","author":"Jahnke","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"103634","DOI":"10.1016\/j.redox.2025.103634","article-title":"Nitro-oleic acid protects from neovascularization, oxidative stress, gliosis and neurodegeneration in oxygen-induced retinopathy","volume":"83","author":"Victoria","year":"2025","journal-title":"Redox Biol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"110796","DOI":"10.1016\/j.exer.2025.110796","article-title":"Glial fibrillary acidic protein, an early and sustained indicator of retinopathy progression","volume":"263","author":"Fernandez","year":"2026","journal-title":"Exp Eye Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/cne.23521","article-title":"The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina","volume":"522","author":"Rodriguez","year":"2014","journal-title":"J Comp Neurol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1167\/iovs.05-1522","article-title":"Potential role of microglia in retinal blood vessel formation","volume":"47","author":"Checchin","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/life12101676","article-title":"Distinguished functions of microglia in the two stages of oxygen-induced retinopathy: a novel target in the treatment of ischemic retinopathy","volume":"12","author":"Zhou","year":"2022","journal-title":"Life"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbrc.2021.11.015","article-title":"Long-term efavirenz exposure induced neuroinflammation and cognitive deficits in C57BL\/6 mice","volume":"584","author":"Zhang","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3389\/fneur.2019.00742","article-title":"Neuropsychiatric and neurocognitive manifestations in HIV-infected children treated with Efavirenz in South Africa-a retrospective case series","volume":"10","author":"Hammond","year":"2019","journal-title":"Front Neurol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"741","DOI":"10.4102\/sajhivmed.v18i1.741","article-title":"Efavirenz and neuropsychiatric effects","volume":"18","author":"Dheda","year":"2017","journal-title":"South Afr J HIV Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1745351\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:27:57Z","timestamp":1771824477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1745351\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":42,"alternative-id":["10.3389\/fmed.2026.1745351"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1745351","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"article-number":"1745351"}}